You are here

ISRO’s GSLV Mark-III launched Planned for First Week of June

The Indian Space Research Organisation (ISRO) is planning to launch the GSLV Mark-III in the first week of June, ISRO Chairman AS Kiran Kumar said on Friday. “GSLV Mark-III is our next launch. We are getting ready. All the systems are in Sriharikota. The integration is currently going on,” he told reporters in Hyderabad while talking about Geosynchronous Satellite Launch Vehicle Mark-III. “The whole process of assembling the various stages and then integrating the satellite into the heat shield, these activities are going on. First week of June is when…

Read More

Should You Invest in the Snapchat IPO? Read This First

Whether you’re obsessed with keeping your Snapstreaks going or have no idea what that means, you may be itching to invest in this week’s initial public offering of Snap Inc., parent company of the popular Snapchat app. The appeal is understandable. For users of the app, owning shares of a company you use every day (or hour) can seem like a good investment. For nonusers, the urban legends of get-rich-quick IPOs are exciting enough on their own. Of course, not every IPO is a success. And even if Snap gets off…

Read More

Brazil issues first license for sale of a cannabis-based drug

Brazilian healthcare regulator Anvisa on Monday said it had issued the country’s first license for sale of a cannabis-based drug in the country after years of legal wrangling with patients. The multiple sclerosistreatment, an oral spray derived from marijuana and developed by Britain’s GW Pharmaceuticals PLC, is known as Sativex internationally and will be sold in Brazil under the brand name Mevatyl. The legal status of cannabis-based drugs has been a thorny issue in Brazil for years, with several patients fighting in the courts to circumvent prohibition. Anvisa has loosened…

Read More

World’s first Chikungunya vaccine developed

US researchers have developed a vaccine for chikungunyafever made from an insect-specific virus that does not have any effect on people, making the vaccine safe and effective. The study indicated that the vaccine quickly produces a strong immune defense and completely protects mice and nonhuman primates from disease when exposed to the chikungunya virus. The findings were published in journal of Nature Medicine. “This vaccine offers efficient, safe and affordable protection against chikungunya and builds the foundation for using viruses that only infect insects to develop vaccines against other insect-borne…

Read More

Malignant malaria claims first life, dengue rages on

At a time when the state is battling to tackle dengue menace, a teenager, who was diagnosed with malignant malaria, died in a private nursing home in Howrah on Monday. This is the first malignant malaria death reported from Kolkata’s suburbs this season. Dengue has already claimed 18 lives in and around Kolkata. The Howrah girl’s mother and brother, also suffering from malignant malaria, are still critical. Parveen Khatoon (16) died in a private nursing home at Howrah’s Baltikuri area. The area falls under Howrah Municipal Corporation’s ward No. 47….

Read More

First next-gen test can detect drug-resistant HIV

First next-gen test can detect drug-resistant HIV (Getty Images) A first-of-its-kind next-generation sequencing test, which can detect HIV drug resistance mutations that conventional tests fail to identify, can be a weapon in the war against AIDS, suggests a new study. Developed by researchers led by Gerd Michel, Charlie Lee and Elian Rakhmanaliev from Vela Diagnostics in Singapore, this test could play a critical role in helping clinicians to optimize HIV treatment regimens, while also helping public health initiatives to minimize the development of global resistance to antiretroviral drugs. Testing for…

Read More